HIV-1 tat inhibits human natural killer cell function by blocking L- type calcium channels

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 2938-2943

  Zocchi, M Raffaella ^a,b   Rubartelli, Anna ^b   Morgavi, Paola ^b   Poggi, Alessandro ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL; CALCIUM ION; CD16 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PHENYLALKYLAMINE; SERINE PROTEINASE; TRANSACTIVATOR PROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CELL INTERACTION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; EFFECTOR CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NATURAL KILLER CELL; PRIORITY JOURNAL; TARGET CELL; TUMOR CELL;

CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CYTOTOXICITY, IMMUNOLOGIC; ESTERASES; GENE PRODUCTS, TAT; HIV-1; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL;

EID: 0032530375     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bonavida, B., J. Katz, and M. Gottlieb. 1986. Mechanisms of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells and partial restoration by IL2. J. Immunol. 137:1157.
2. Fauci, A. S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617.
3. Sirianni, M. C., F. Tagliaferri, and F. Aiuti. 1990. Pathogenesis of the natural killer cell deficiency in AIDS. Immunol. Today 11:81.
4. Ullum, H., P. C. Gotzsche, J. Victor, E. Dickmeiss, P. Skinhoj, and B. K. Pedersen. 1995. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J. Exp. Med. 182:789.
5. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
6. O'Shea, J., and J. R. Ortaldo. 1992. The biology of natural killer cells: insights into the molecular basis of function. In The Natural Killer Cell. C. E. Lewis and J. O. McGee, eds. Oxford University Press, Oxford, U.K. p. 1.
7. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.
8. Lanier, L. L., and J. H. Phillips. 1996. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today 17:86.
9. Leibson, P. J. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6:655.
10. Poggi, A., R. Pardi, N. Pella, L. Morelli, F. Spada, S. Sivori, M. Vitale, V. Revello, A. Moretta, and L. Moretta. 1993. CD45-mediated regulation of LFA-1 function in human natural killer cells: anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA-1 molecules. Eur. J. Immunol. 23:2454.
11. Pardi, R., J. R. Bender, C. Dettori, E. Gianazza, and E. G. Engleman. 1989. Heterogeneous distribution and transmembrane signaling properties of LFA-1 in human lymphocyte subsets. J. Immunol. 143:3157.
12. 2+ in activation of mature cytotoxic T-lymphocytes for lysis. J. Immunol. 139:3573.
13. Sadighi Akcha, A. A., N. J. Willmott, K. Brickley, A. C. Dolphin, A. Galione, and S. V. Hunt. 1996. Anti-Ig-induced calcium influx in rat B lymphocytes mediated by cGMP through a dihydropyridine-sensitive channel. J. Biol. Chem. 271:7297.
14. Poggi, A., A. Rubartelli, and M. R. Zocchi. 1998. Involvement of dihydropyridine-sensitive calcium channels in human dendritic cell function: competition by HIV-1 Tat. J. Biol. Chem. 273:7205.
15. Glossmann, H., and D. R. Ferry. 1985. Assay for calcium channels. Methods Enzymol. 109:513.
16. Catterall, W. A. 1995. Structure and function of voltage gated ion channels. Annu. Rev. Biochem. 64:493.
17. Frankel, A. D., and C. O. Pabo. 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189.
18. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcomas lesions of AIDS patients. Nature 345:84.
19. Li, C. J., D. J. Friedman, C. Wang, V. Metelev, and A. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429.
20. 2+ ions and cytosolic factors. J. Biol. Chem. 272:11256.
21. Viscidi, R. P., K. Mayur, H. M. Lederman, and A. D. Frankel. 1989. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246:1606.
22. Scala, G., M. R. Ruocco, C. Ambrosino, M. Mallardo, V. Giordano, F. Baldassarre, E. Dragonetti, I. Quinto, and S. Venuta. 1994. The expression of interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med. 179:961.
23. Westendorp, M. O., M. Li-Weber, R. W. Frank, and P. H. Krammer. 1994. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:4177.
24. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497.
25. Zocchi, M. R., A. Poggi, and A. Rubartelli. 1997. The RGD-containing domain of exogenous HIV-1 Tat inhibit the engulfment of apoptotic bodies by dendritic cells. AIDS 11:1227.
26. Pende, D., R. Biassoni, C. Cantoni, S. Verdiani, M. Falco, C. Di Donato, L. Accame, C. Bottino, A. Moretta, and L. Moretta. 1996. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140kD disulfide-linked dimer. J. Exp. Med. 184:1.
27. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem 260: 3440.
28. 2+ channels as revealed by fluorescence resonance energy transfer. Biochemistry 33:11875.
29. Poggi, A., N. Pella, L. Morelli, F. Spada, V. Revello, S. Sivori, R. Augugliaro, L. Moretta, and A. Moretta. 1995. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex cytolytic activity in humans. Eur. J. Immunol. 25:369.
30. Shiver, J. W., L. Su, and P. A. Henkart. 1992. Cytotoxicity with target DNA breakdown by rat basophilic leukaemia cells expressing both cytolysin and granzyme A. Cell 71:315.
31. Zocchi, M. R., E. Ferrero, B. Leone, P. Rovere, E. Bianchi, E. Toninelli, and R. Pardi. 1996. CD31/PECAM1-driven chemokine-independent transmigration of human T lymphocytes. Eur. J. Immunol. 26:759.
32. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
33. Poggi, A., F. Spada, P. Costa, E. Tomasello, V. Revello, N. Pella, M. R. Zocchi, and L. Moretta. 1996. Dissection of lymphocyte function associated antigen 1-dependent adhesion and signal transduction in human natural killer cells shown by the use of cholera or pertussis toxin. Eur. J. Immunol. 26:967.
34. Hille, B. 1994. Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurol. Sci. 17:531.
35. Oh, S. K., S. Cerda, B.G. Lee, C. C. Blanchard, J. E. Walker, and K. Hartshorn. 1993. Partial purification and identification of an immunosuppressive factor in AIDS sera. AIDS Res. Hum. Retroviruses 9:365.
36. Albini, A., R. Benelli R, M. Presta, M. Rusnati, M. Ziche, A. Rubartelli, G. Paglialunga, F. Bussolino, and D. Noonan. 1996. HIV-tat protein is an heparin-binding angiogenic growth factor. Oncogene 12:289.